Bristol Myers Squibb turns to China to develop new drugs in newest cross-continent collaboration

AI Summary

Bristol Myers Squibb has established a collaboration with a Chinese company aimed at developing new drugs, signaling a growing trend of cross-continent partnerships in the pharmaceutical industry. This venture may influence global healthcare markets.

U.S. drugmaker Bristol Myers Squibb inked a partnership with a Chinese company that some say could mark the next wave of collaboration across continents.